Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
This holiday season, send a card that spreads joy to loved ones and supports a meaningful cause—each purchase contributes to funding brain tumor research and critical support programs. Holiday Cards
by Britt McHenry As I was wheeled into the operating room at Johns Hopkins on March 4, 2020 for an eight-hour craniotomy, for just a second I thought, “I don’t
by Tia Mazzone In October 2022, Brad’s life took a drastic turn when he started experiencing intense headaches. Initially, these symptoms were attributed to a sinus infection. His wife, Tia,
by Debbie Drews Embracing Anticipatory Grief: Our Journey with Glioblastoma In 2022, my husband Tom, my partner of 20 years, was diagnosed with Glioblastoma (GBM), a form of brain cancer
ABTA President and CEO Ralph DeVitto is retiring February 2025, after serving the ABTA for seven years. His legacy highlights remarkable achievements, including significantly increasing the organization’s revenue resulting in
Meet the 2024 ABTA grant recipients at the forefront of the brain tumor research community. Donations from individuals to large groups in the brain tumor community have been the engine
For oligodendroglioma survivor Karl Schmidt and his friends, Alex Budde and Treven Goldsmith, a brain tumor journey transformed their 10+ year friendship and revealed the profound impact they could make
**Sponsored by Plus Therapeutics. This content is not an endorsement from the ABTA.** ReSPECT-GBM Patient Story | Jim, Recurrent Glioblastoma Survivor Dr. Jim Stockand, a dedicated educator with a PhD
** Sponsored by Imvax. This content is not an endorsement from the ABTA.** Imvax is a pioneering clinical biotechnology company developing personalized cancer treatments specifically designed for glioblastoma (GBM) patients.
Always free for patients & caregivers
Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor
Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.
